Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Movement disorders
•
Pharmacology
How do you convert between tetrabenazine, deutetrabenazine, or valbenazine for management of tardive dyskinesia?
To ensure equivalent dosing due to insurance or formulary changes.
Related Questions
Which essential tremor phenotypes benefit most from wearable peripheral nerve stimulator devices?
Do you prescribe respiratory muscle training (RMT) devices to patients with dysphagia?
Do you consider DBS for Essential Tremor in patients who already underwent Focused Ultrasound Thalamotomy?
What is your approach to Tardive Dyskinesia when VMAT2 inhibitors are ineffective or unaffordable?
How effective do you find MAO-B inhibitors for the treatment of Parkinson's disease?
When should you suspect that palatal tremor could be a functional neurologic disorder?
What do you do for a patient with Parkinson's Disease and orthostatic hypotension who has failed midodrine, fludrocortisone, droxidopa, pyridostigmine, and atomoxetine?
Which imaging features do you use when considering Normal Pressure Hydrocephalus to decide whether to proceed with large-volume LP or lumbar drain trial?
What considerations should you discuss with patients prior to genetic testing for suspected Huntington disease?
Do you ever delay starting levodopa in patients with Parkinson's disease?